🇺🇸 FDA
Patent

US 9629816

Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same

granted A61KA61K31/00A61K31/133

Quick answer

US patent 9629816 (Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/00, A61K31/133, A61K31/136, A61K31/137